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Abstract 
Purpose of Review: There is great interest in developing tools to measure healthy ageing and to identify 
early stages of health impairment which may guide the implementation of interventions to prevent or 
delay the development of disease, disability and mortality. Here we review the most recent developments 
directed to operationalise, and test, definitions of healthy ageing. 
Recent Findings: There is lack of consensus about how to define healthy ageing and, unsurprisingly, 
diversity in the instruments for its measurement. However, progress is being made in describing and in 
devising tools to capture the healthy ageing phenotype. Attempts to measure healthy ageing have relied 
primarily on cross-sectional data collected in older people. More recent studies have assessed the healthy 
ageing phenotype using markers of multiple functional domains and have used longitudinal data to model 
the dynamics and trajectories of healthy ageing.  
Summary: Given the complexity of the ageing process, no single measure is able to predict the ageing 
trajectory. Current attempts to operationalise the healthy ageing phenotype have relied on markers and 
data from earlier cohort studies and are limited by the tools used to collect data in those studies. Such data 
are often unsuitable to detect early subtle declines in function and/ or are inappropriate for use in younger 
old-adults. Future studies employing more objective and novel markers of healthy ageing are likely to 
offer opportunities to define and operationalise the healthy ageing phenotype.  
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 Introduction 
What is ageing? Ageing has been described as the biological changes that occur in an individual that are 
associated with a gradual decline in function. For most, ageing is experienced as a slow deterioration 
resulting eventually in frailty, disability, disease and death. However, evidence from model systems and 
from human studies shows that the ageing process is malleable, the ageing trajectory can be slowed and 
the link with disease weakened. Given favourable circumstances, individuals can maintain good physical 
and cognitive function. In part those circumstances are genetic but socioeconomic factors and lifestyle are 
major determinants. Recent data from the USA illustrate the strong association between higher income (as 
a surrogate for more favourable circumstances) and longevity (1). This study also showed that whilst those 
with higher income gained about 0.2 years of life extra per year over the period 2000 – 2014, the poorest 
had no improvements. In addition, Chetty and colleagues noted that income was associated strongly with 
higher physical activity and with lower likelihood for smoking and obesity – lifestyle-related factors 
which are established modulators of ageing and risk of age-related disease (1). 
Reaching consensus on how healthy ageing should be defined has proven to be a difficult task. This lack 
of consensus is a significant impediment not only for research but also for national surveillance 
programmes, public health interventions and for commercial developments. This difficulty is due partly to 
the different perspectives, expectations and aims of researchers from different disciplines. While from a 
scientific perspective the preservation of health and function is a priority, evidence indicates that other 
more subjective aspects of wellbeing are also important to the individual. Interviews with older people 
have indicated that wellbeing is produced by having the “capability” to mobilise resources to achieve 
contextually appropriate goals and to respond effectively to changing personal circumstances (2). Lastly, 
there is heterogeneity in the terminology used to denote the concept of healthy ageing in the literature. For 
the purpose of the present review we will adopt the term healthy ageing.  
The importance of defining and measuring healthy ageing is underlined by the fact that the global 
population is ageing; By 2080, 29% of the European population will be aged > 65 years (3). This is due to 
the combination of reduced birth rate and increased life expectancy. To reduce the risk of economic 
instabilities and to prevent social collapse as a result of too few people in economically productive work, 
several countries are raising the retirement age to maintain the workforce and to reduce the pension 
burden associated with greater longevity. In addition, because ageing is the major driver of most common 
complex diseases, the chronic disease burden is increasing (4). These pressures emphasise the importance 
of finding ways to enable people to age better and to maintain good function and high levels of wellbeing. 
To facilitate the development of targeted interventions which may be more resource efficient, it would be 
helpful to distinguish those who are ageing well from those who are ageing less well. In other words, we 
need to be able to identify a healthy ageing phenotype  (5). The benefits of maintaining good health into 
old age include saving health care costs, improving quality of life, and enabling older people to continue 
to participate productively in society and to offer their stability, heightened capacity for synthetic problem 
solving, increased ability to manage conflicts, and ability to consider perspectives from other age groups 
(6). 
Models of healthy ageing 
Cellular dysfunction is the biological basis for the age-related decline in function and for the increasing 
risk of frailty, disability and disease, the cardinal features of ageing. The accumulated macromolecular 
damage in ageing is pervasive affecting virtually every cellular, tissue and whole body function and is 
remarkably similar in multiple species. This observation underpinned the recent proposal for 9 hallmarks 
of ageing (7) which help to conceptualise and systematise a highly complex collection of processes. 
Importantly, the ageing process is plastic and the accumulation of molecular damage and cell dysfunction 
can be slowed (8). Models of healthy ageing have been based on Rowe and Kahn’s 1987 proposal which 
differentiated between healthy older individuals and those with disease and/or disability (6). More recently 
there has been emphasis on models which include both subjective e.g. psychosocial wellbeing as well as 
objective, i.e. biological, measurements (9). Psychological based models emphasise “how” healthy ageing 
occurs whereas the biological models emphasise the “what” (6).  
The different conceptual frameworks of healthy ageing models have been reviewed. Martinson and 
Berridge conducted a systematic review of critiques of successful ageing models and the suggestions for 
improvement from the social gerontology literature (10). More recently Anton et al. provided an overview 
which focussed on physical function, and the role of interventions that may enhance mobility and physical 
function and so promote independence among older adults (11).  
Healthy ageing phenotypes 
Currently most literature focuses on morbidity and mortality as ageing phenotypes. Our group, and others, 
have emphasised the need to focus on a combination of objective and subjective outcomes including 
physical capability, cognitive function, physiological and metabolic health, and psychosocial well-being 
(9), In addition, the importance of assessing sensorial functions has been identified (12). Olfactory 
function may be an indicator of the integrity of the ageing brain in older people, since smell dysfunction is 
among the earliest “preclinical” signs of neurodegenerative diseases such as Alzheimer disease and 
sporadic Parkinson's disease (13). 
Frailty vs. Healthy ageing 
It could be argued that the development of frailty is an example of failure to age healthily. Frailty 
indicators have been extensively validated in multiple populations for their ability to predict age-related 
adverse health outcomes ranging from falls to mortality in elderly populations (14). Measures of frailty 
have been reviewed recently by Roppolo et al. (2015) who showed that different instruments captured 
different characteristics of frailty and that whether an individual is classified as frail or not depends on the 
index of frailty used in the assessment (15). Whilst frailty may be evidence of a failure to age healthily, it 
is unlikely that assessments which are used to assess frailty would be sufficient to assess healthy ageing. 
This is because the instruments used in such assessments are designed for individuals experiencing a 
substantial degree of disability or illness and are usually applicable only to the oldest segments of the 
population. Because of floor and ceiling problems, such tools would be insensitive when applied to 
younger individuals. However, recently, Romero-Ortuno proposed that a simple 5-item index called the 
Frailty Instrument (FIt) for primary care which is based on the Survey of Health, Ageing and Retirement in 
Europe (SHARE) may be useful for assessing and monitoring frailty in community dwelling people over 
the age of 50 (16). 
Current evidence on operationalisation of definitions of healthy ageing 
To identify recent studies operationalising healthy ageing, a systematic search was performed using 
PubMed from 01-01-2013 until 01-05-2016. Publications were included if the authors intended to measure 
the healthy ageing phenotype or employed a multidimensional approach to measure healthy ageing. Using 
this strategy, twelve studies (17-28) were found (Table 1). All tools which are included in this brief review 
were multidimensional.  
Although evidence is still scarce, we identified several studies that focused on operationalising healthy 
ageing. Among the papers identified, the very recent paper by Tampubolon (28) is novel in using the 
concept of the healthy ageing phenotype (9) and in assessing the trajectories of some of the biomarkers 
proposed in that model among participants of the English Longitudinal Study of Ageing (ELSA). ELSA is 
a prospective, nationally-representative sample of people aged ≥ 50 years. The biomarkers included 
measures of cardiovascular function, glucose homeostasis, lung function, adiposity, lipid metabolism, and 
inflammation. This study showed a secular decline in healthy ageing from middle-age, which was sharper 
among women and differed by socioeconomic position. Those with greater material advantage and higher 
educational attainment had smaller declines in biomarkers of healthy ageing (28). In addition, the findings 
were in line with previous studies (e.g. Pruchno et.al.) suggesting that maintenance of healthy ageing at 
follow up was more common among men, those who were working, the married, and those having better 
social relationships at baseline (25).  
Two other studies proposed different tools to assess healthy ageing (19, 20). Tyrovolas et al. used a 
composite index of healthy ageing which included 10 elements viz. education, financial status, social 
activities (subdivided into friends, family and excursions per year), CVD risk, BMI, depression, physical 
activity and Mediterranean diet. Using data on older adults from Mediterranean countries, these authors 
reported that a 1-point increase in their 10-point index was associated with one less annual visit to health 
centres. Using data from the Medical Research Council’s Cognitive Function and Aging Study (CFAS), 
Cosco et al. tested an ageing index based on activities of daily living, cognitive function, and subjective 
aspects such as personal resources and engagement (19). These authors reported that their index was 
associated with use of health services, informal care and other services such as meals on wheels.  
The Whitehall study, a longitudinal cohort of civil servants in the UK with a long follow-up period 
(median 16 years) and a large sample size, has been recently used to classify individuals as successfully 
ageing or not. In this study, healthy ageing has been defined as survival in the follow up period (mean age 
60), with no diagnosis of chronic disease or abnormal oral glucose tolerance test, no mental health 
problems and normal cognitive (Alice Heim 4-I, short-term verbal memory test, 2 tests of verbal fluency, 
Mill Hill Vocabulary test), cardio metabolic (SBP), respiratory (FEV1/height2 in L/m2) and 
musculoskeletal function (walking speed over a clearly marked 8-foot walking course) (29).  
DISCUSSION 
To date, few studies have attempted to operationalise healthy ageing using comprehensive and multi-
dimensional approaches (such as that proposed by Lara et al. 2013 [12]) and to apply the resulting tools to 
data from current longitudinal cohorts. Current studies have relied on data with only partial or proxy 
measures for each of the different domains associated with the healthy ageing phenotype. The available 
indices focus on different combinations of domains of healthy ageing but commonly focus on cognitive 
function and measures of physical capability. Decline in cognitive function is a hallmark of ageing and 
recent data from the Sydney Memory and Ageing Study (an observational population-based cohort study) 
showed that both baseline cognitive ability and decline in cognitive ability over 2 years predicted 
mortality, even in the absence of dementia (30). Cognitive decline also has important financial, personal 
and societal consequences, and is the cause of 40% of admissions to institutionalised care in the UK. Most 
of the studies reviewed included at least one measure of global cognitive functioning, commonly the mini 
mental state examination (MMSE). This tool has been used widely in, and accepted as appropriate for, 
elderly populations. However its ability to detect subtle deficiencies, namely mild cognitive impairment 
(31), or cognitive changes at high levels of cognition such as among highly educated people  has been 
questioned. A recent Cochrane review concluded that the MMSE was insufficient as a stand-alone single-
administration test in the identification of MCI patients who could develop dementia (31). Subtle changes 
in cognitive function can be meaningful and the majority of tools ignore this by using tools designed to 
identify more evident declines in cognitive function and it is likely that "one size does not fit all" in 
cognitive screening (31).  
The reviewed studies have mostly used activities of daily living, with few using more objective measures 
of gait or walking tests. All but one study focused on older populations, those aged 70+ and often in 85 to 
90+ individuals. Puchno et al. found that midlife predictors of healthy ageing differed from those which 
apply later in life (25). In addition, it appears that some biomarkers of ageing which appear robust in 
younger old individuals may not be valid in very old people. Indeed, in some cases the reverse may apply 
e.g. higher BP is a risk factor in younger people but may be a protective factor in very old people 
(32).Overall, assessment of the utility of markers of healthy ageing is limited by uncertainties and lack of 
consensus about the appropriate outcome measures to be used in such assessments. Whilst earlier studies 
have focussed on hard end points such as death or diagnosis of major age-related disease, some recent 
studies have considered other outcomes such as use of health services (e.g. hospitalisations).  
None of the studies identified in the current search have used markers of sensorial functions. Sensory 
functions are critical for normal function, independence and social interaction and most decline with age 
(12). Smell dysfunction is one of the earliest indications of preclinical neurodegenerative diseases (13) but 
the predictive value of sensory function for age-related health outcomes has yet to be validated (12). 
Lastly, few tools consider social function in the assessment of the healthy ageing trajectory despite the fact 
that social interactions and personal support networks are strongly associated with both morbidity and 
mortality (33).  
Conclusion 
Healthy ageing is the maintenance of a range of functions including physical capability, cognition, 
physiology, social, sensory and psychological wellbeing. A suitable approach to measure healthy ageing 
should include both subjective and objective assessments of as many as possible of these factors since the 
complex interplay of these factors determines health and wellbeing outcomes (11),  However, this must be 
balanced against the resource requirements for more comprehensive assessments and future research 
should aim to identify the minimum set of measures which provides reliable prediction of the ageing 
trajectory and which could be used as outcome measures for interventions [12]. However, current models 
of healthy ageing remain incomplete; the operationalisation of the healthy ageing phenotype is a work in 
progress. 
Key Points 
 The lack of an agreed definition of healthy ageing limits the development of tools for its 
measurements and, therefore, the ability to predict the ageing trajectory. 
 Current models focus on absence of frailty and on functional status including the ability to carry 
out the activities of daily living.  
 Conceptualisation and operationalization of the healthy ageing phenotype offers a potential route 
to the development of tools for assessing ageing which are age-, sex-and culturally-appropriate. 
 Tools for healthy ageing will need to be validated in younger and older populations in a range of 
settings to determine their generalizability. 
 Testing of tools for healthy ageing is limited by uncertainties about the most appropriate outcomes 
measures to use at different stages in the life-course. Outcome measures such as hospitalisation, 
institutionalisation and disability which are sensitive in younger populations need to be developed 
and validated. 
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Table 1. Characteristics of studies  
 
(Legend to table 1) 
Abbreviations: SBP systolic blood pressure, FVC forced vital capacity,  FEV-1 forced expiratory volume 
in one second, MMSE- Mini-mental state examination, sCRT serum creatinine, Glc glucose, ADL 
Activities of daily living , TChol total cholesterol, HDL High density lipoprotein, ALT Alanine 
aminotransferase, CRT creatinine, Trigly Triglycerides, IADL instrumental activities of daily living, 
sMMSE standardised MMSE, PA Physical activity, WC waist circumference, MedDietScore 
Mediterranean diet, PANAS Positive and Negative affect schedule, HBA1c, FEV1 Forced expiratory 
volume in one second/height2 in L/m2, CBVD cerebrovascular disease, HGS handgrip strength, CVD 
cardiovascular disease, COPD chronic obstructive pulmonary disease.. 
 
